FDAnews
www.fdanews.com/articles/85244-spectrum-pharmaceuticals-announces-filing-of-thirteenth-anda-for-an-injectable-drug-with-the-fda

SPECTRUM PHARMACEUTICALS ANNOUNCES FILING OF THIRTEENTH ANDA, FOR AN INJECTABLE DRUG, WITH THE FDA

March 13, 2006

Spectrum Pharmaceuticals, Inc. announced that it has filed its thirteenth Abbreviated New Drug Application (ANDA), which is for an injectable drug, with the U.S. Food and Drug Administration (FDA). Spectrum Pharmaceuticals currently has nine other ANDAs that are under review at the FDA, including an ANDA with Paragraph IV certification for sumatriptan succinate injection, the generic form of GlaxoSmithKline's Imitrex(R) injection.
Finanzen.net